Kunming Longjin Pharmaceutical Denies Media Reports on Possible Backdoor Listing Deal With Dalian Wanda
Liao Shumin
/SOURCE : Yicai
Kunming Longjin Pharmaceutical Denies Media Reports on Possible Backdoor Listing Deal With Dalian Wanda

(Yicai Global) Nov. 10 -- Kunming Longjin Pharmaceutical Co. [SHE:002750] has not negotiated with Dalian Wanda Commercial Properties Co. [HKG:3699] or its financial adviser on any backdoor listing, and had no any cooperation intention with the latter either, the company's board of directors said in a statement today.

Kunming Longjin made the above statement upon a media report that suggested Dalian Wanda may be following the case of Qihoo 360, claiming that Kunming Longjin  is the potential target of backdoor listing by Dalian Wanda Commercial Properties.

On Nov. 6, an article about SJEC Corp. [SHA:601313] and Qihoo 360, bylined "Xiang Xiaotian" on an official WeChat account, went viral on the net. On Nov. 8, a media report about Dalian Wanda suggested a similar type of relationship with Kunming Longjin.

Follow Yicai Global on
Keywords: Kunming Longjin Pharmaceutical , Dalian Wanda Commercial Properties , Backdoor Listing